Reports for BAUSCH HEALTH, CANADA INC.

Company Name

BAUSCH HEALTH, CANADA INC.

Totals

Shortage reports

295

Actual shortage: 9 (3%)
Anticipated shortage: 3 (1%)
Avoided shortage: 23 (8%)
Resolved: 260 (88%)

Discontinuation Reports

1

To be discontinued: 0 (0%)
Discontinued: 1 (100%)
Reversed: 0 (0%)

Late reports

88 (30%)

Overdue reports

2 (17%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ROFACT 300MG CAPSULE Avoided shortage 2023-03-13 2023-03-27 186883
BIACNA TOPICAL GEL 0.025% 1.2% GEL Anticipated shortage 2023-03-23 2023-03-23 187755
QVAR 100MCG METERED-DOSE AEROSOL Resolved 2022-12-07 2023-03-23 177248
NIDAGEL 0.75% GEL Actual shortage 2023-02-08 2023-03-23 183891
CUPRIMINE 250MG CAPSULE Avoided shortage 2023-03-13 2023-03-23 186886
BENZACLIN 5% 1% GEL Avoided shortage 2022-12-21 2023-03-23 179119
DIASTAT 15MG GEL Actual shortage 2022-12-07 2023-03-23 177261
DELATESTRYL 200MG SOLUTION Actual shortage 2023-01-18 2023-03-13 181436
LODALIS 625MG TABLET Resolved 2023-01-11 2023-03-04 180700
QVAR 50MCG METERED-DOSE AEROSOL Anticipated shortage 2023-03-03 2023-03-03 186121
LOPROX 1% LOTION Resolved 2022-12-21 2023-03-03 179123
ROFACT 300MG CAPSULE Resolved 2022-12-02 2023-02-24 176953
ROFACT 150MG CAPSULE Resolved 2022-12-07 2023-02-24 177254
XERESE 1% 5% CREAM Anticipated shortage 2023-02-08 2023-02-08 183894
NIDAGEL 0.75% GEL Resolved 2022-11-09 2023-01-25 174138
ARISTOCORT R 0.1% CREAM Actual shortage 2023-01-16 2023-01-17 181211
RALIVIA 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-07 2023-01-11 177241
MANERIX 150MG TABLET Resolved 2022-12-21 2023-01-04 179114
DELATESTRYL 200MG SOLUTION Resolved 2022-12-02 2022-12-21 176956
LOPROX 1% CREAM Resolved 2022-09-12 2022-12-07 169138

Showing 1 to 20 of 295

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
THEOLAIR 80MG SOLUTION Discontinued 2021-04-26 2021-04-27 138081

Showing 1 to 1 of 1